rs695103

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004385.5(VCAN):​c.9379+7T>C variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.124 in 1,608,182 control chromosomes in the GnomAD database, including 15,074 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.11 ( 1115 hom., cov: 33)
Exomes 𝑓: 0.13 ( 13959 hom. )

Consequence

VCAN
NM_004385.5 splice_region, intron

Scores

2
Splicing: ADA: 0.00001425
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.685

Publications

8 publications found
Variant links:
Genes affected
VCAN (HGNC:2464): (versican) This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
VCAN-AS1 (HGNC:40163): (VCAN antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-83545657-T-C is Benign according to our data. Variant chr5-83545657-T-C is described in ClinVar as Benign. ClinVar VariationId is 259377.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.313 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VCANNM_004385.5 linkc.9379+7T>C splice_region_variant, intron_variant Intron 9 of 14 ENST00000265077.8 NP_004376.2 P13611-1A0A024RAQ9Q59FG9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VCANENST00000265077.8 linkc.9379+7T>C splice_region_variant, intron_variant Intron 9 of 14 1 NM_004385.5 ENSP00000265077.3 P13611-1

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16105
AN:
152120
Hom.:
1113
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0529
Gnomad AMI
AF:
0.0395
Gnomad AMR
AF:
0.0731
Gnomad ASJ
AF:
0.131
Gnomad EAS
AF:
0.226
Gnomad SAS
AF:
0.326
Gnomad FIN
AF:
0.139
Gnomad MID
AF:
0.184
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.115
GnomAD2 exomes
AF:
0.139
AC:
34968
AN:
251054
AF XY:
0.152
show subpopulations
Gnomad AFR exome
AF:
0.0504
Gnomad AMR exome
AF:
0.0572
Gnomad ASJ exome
AF:
0.140
Gnomad EAS exome
AF:
0.232
Gnomad FIN exome
AF:
0.141
Gnomad NFE exome
AF:
0.114
Gnomad OTH exome
AF:
0.132
GnomAD4 exome
AF:
0.126
AC:
183889
AN:
1455944
Hom.:
13959
Cov.:
29
AF XY:
0.133
AC XY:
96256
AN XY:
724804
show subpopulations
African (AFR)
AF:
0.0523
AC:
1744
AN:
33316
American (AMR)
AF:
0.0613
AC:
2739
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.136
AC:
3556
AN:
26102
East Asian (EAS)
AF:
0.196
AC:
7753
AN:
39654
South Asian (SAS)
AF:
0.314
AC:
27052
AN:
86158
European-Finnish (FIN)
AF:
0.140
AC:
7476
AN:
53416
Middle Eastern (MID)
AF:
0.186
AC:
1070
AN:
5760
European-Non Finnish (NFE)
AF:
0.112
AC:
124214
AN:
1106608
Other (OTH)
AF:
0.138
AC:
8285
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
8097
16195
24292
32390
40487
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4694
9388
14082
18776
23470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.106
AC:
16116
AN:
152238
Hom.:
1115
Cov.:
33
AF XY:
0.113
AC XY:
8426
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.0529
AC:
2199
AN:
41560
American (AMR)
AF:
0.0732
AC:
1120
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.131
AC:
454
AN:
3470
East Asian (EAS)
AF:
0.226
AC:
1172
AN:
5176
South Asian (SAS)
AF:
0.327
AC:
1576
AN:
4822
European-Finnish (FIN)
AF:
0.139
AC:
1472
AN:
10590
Middle Eastern (MID)
AF:
0.194
AC:
57
AN:
294
European-Non Finnish (NFE)
AF:
0.115
AC:
7788
AN:
68002
Other (OTH)
AF:
0.114
AC:
242
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
732
1464
2196
2928
3660
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.112
Hom.:
2069
Bravo
AF:
0.0935
Asia WGS
AF:
0.234
AC:
811
AN:
3476
EpiCase
AF:
0.120
EpiControl
AF:
0.120

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Wagner syndrome Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 16, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Vitreoretinopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
6.8
DANN
Benign
0.48
PhyloP100
0.69
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000014
dbscSNV1_RF
Benign
0.0020
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs695103; hg19: chr5-82841476; COSMIC: COSV54100178; API